Michel Sadelain
MS
Michel Sadelain
Co-founder
Rate
About
Director of Columbia Initiative in Cell Engineering & Therapy. Pioneer of CAR-T cell therapy and T-cell engineering. Recipient of 2024 Breakthrough Prize in Life Sciences. Created first effective CAR-T cells in 2002.
Frequently asked
Who is Michel Sadelain?
Director of Columbia Initiative in Cell Engineering & Therapy. Pioneer of CAR-T cell therapy and T-cell engineering. Recipient of 2024 Breakthrough Prize in Life Sciences. Created first effective CAR-T cells in 2002.
What is Michel Sadelain's current role?
Michel Sadelain is currently Co-founder.
Where is Michel Sadelain based?
Michel Sadelain is based in New York, United States.
Comments
No comments yet. Be the first to share your take.
Profile
About Michel Sadelain
Michel Sadelain is Co-founder. Michel is a founder of Juno Therapeutics. Based in New York, United States. This profile tracks their companies, funding activity, and news mentions across the AI ecosystem.